{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:56:40Z","timestamp":1782845800673,"version":"3.54.5"},"reference-count":20,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The 75-g oral glucose tolerance test (OGTT) remains the optimal diagnostic test for use in pregnancy but needs to be performed in the clinical setting. The GTT@home OGTT device offers the potential to enable patients to perform the test at home using capillary blood samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to determine the accuracy of the GTT@home device compared to the routine National Health Service laboratory reference method using blood samples during an OGTT from pregnant women at high risk of developing gestational diabetes mellitus (GDM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 65 women (aged &gt;18 y), at high risk for GDM (per the National Institute for Health and Care Excellence guidelines) were recruited for this performance evaluation. Following an overnight fast, participants went for a 75-g OGTT. Fasting and 2-hour capillary glucose levels were measured using the GTT@home device with corresponding venous samples measured in the laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The complete data for analysis was available for 61\/65 devices. The overall bias for the GTT@home device was +0.16 mmol\/L. Correlation analysis of the clinical performance of the two methods using a surveillance error grid showed 79.8% of results in the lowest, 16.9% in the \u201cslight, lower\u201d and 2.4% in the \u201cslight, higher\u201d risk categories. Only 0.8% were \u201cmoderate, lower\u201d risk, and none were in any higher risk categories. There was agreement in the classification in 54\/61 cases. The GTT@home device under-classified 2 cases and over-classified 5 cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The GTT@home device worked well in a controlled, antenatal clinical setting. Differences in classification observed were generally due to small differences in glucose values close to the diagnostic cut-offs. The GTT@home device shows promise for home testing of glucose tolerance in pregnant women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/69695","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T14:50:06Z","timestamp":1746888606000},"page":"e69695-e69695","source":"Crossref","is-referenced-by-count":0,"title":["Use of the GTT@home Oral Glucose Tolerance Test Kit in Gestational Diabetes Mellitus: Performance Evaluation Study"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-862X","authenticated-orcid":false,"given":"Gareth J","family":"Dunseath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-6530","authenticated-orcid":false,"given":"Stephen D","family":"Luzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-9312","authenticated-orcid":false,"given":"Wai Yee","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5841-8309","authenticated-orcid":false,"given":"Sharon N","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3111-5593","authenticated-orcid":false,"given":"Nicola","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6400-6933","authenticated-orcid":false,"given":"Mahmoud","family":"Chokor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-9715","authenticated-orcid":false,"given":"Michael","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1671-627X","authenticated-orcid":false,"given":"Rajesh","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"R1","unstructured":"Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. URL: https:\/\/stacks.cdc.gov\/view\/cdc\/5613\/cdc_5613_DS1.pdf [Accessed 28-01-2026]"},{"key":"R2","unstructured":"NICE guideline NG3 diabetes in pregnancy: management from preconception to the postnatal period. NICE. Feb 25, 2015. URL: https:\/\/www.nice.org.uk\/guidance\/ng3 [Accessed 28-01-2026]"},{"issue":"5","key":"R3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/1471-0528.16482","article-title":"Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single-centre observational study","volume":"128","author":"van-de-l\u2019Isle","journal-title":"BJOG"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/j.deman.2021.100023","article-title":"Performance of guidelines for the screening and diagnosis of gestational diabetes mellitus during the COVID-19 pandemic: a scoping review of the guidelines and diagnostic studies evaluating the recommended testing strategies","volume":"3","author":"Curtis","journal-title":"Diabet Epidemiol Manag"},{"issue":"3","key":"R5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pcd.2015.11.003","article-title":"Which sample tube should be used for routine glucose determination?","volume":"10","author":"Bonetti","journal-title":"Prim Care Diabetes"},{"issue":"7-8","key":"R6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.clinbiochem.2014.01.011","article-title":"The shift from fluoride\/oxalate to acid citrate\/fluoride blood collection tubes for glucose testing - the impact upon patient results","volume":"47","author":"Norman","journal-title":"Clin Biochem"},{"issue":"5","key":"R7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1373\/clinchem.2008.121707","article-title":"Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis","volume":"55","author":"Gambino","journal-title":"Clin Chem"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2017.12.003","article-title":"Blood glucose determination: effect of tube additives","volume":"84","author":"Lippi","journal-title":"Adv Clin Chem"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0004563216665868","article-title":"Effects of time and temperature on 48 routine chemistry, haematology and coagulation analytes in whole blood samples","volume":"54","author":"van Balveren","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/clinchem\/hvz027","article-title":"Diagnosis of gestational diabetes mellitus will be flawed until we can measure glucose","volume":"66","author":"Bruns","journal-title":"Clin Chem"},{"issue":"7","key":"R11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.2337\/dc20-0304","article-title":"Strict preanalytical oral glucose tolerance test blood sample handling is essential for diagnosing gestational diabetes mellitus","volume":"43","author":"Potter","journal-title":"Diabetes Care"},{"issue":"6","key":"R12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2337\/dc11-9997","article-title":"Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"34","author":"Sacks","journal-title":"Diabetes Care"},{"issue":"8","key":"R13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/clinchem\/hvad080","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"69","author":"Sacks","journal-title":"Clin Chem"},{"issue":"7","key":"R14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/dme.13961","article-title":"Performance evaluation of a self\u2010administered home oral glucose tolerance test kit in a controlled clinical research setting","volume":"36","author":"Dunseath","journal-title":"Diabet Med"},{"issue":"8476","key":"R15","first-page":"307","volume":"1","author":"Bland","journal-title":"Lancet"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1932296814539589","article-title":"The surveillance error grid","volume":"8","author":"Klonoff","journal-title":"J Diabetes Sci Technol"},{"issue":"6947","key":"R17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: Predictive values","volume":"309","author":"Altman","journal-title":"BMJ"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117414","article-title":"The impact of inter-laboratory glucose bias on the diagnosis of gestational diabetes mellitus: comparison of common automated central laboratory methods","volume":"546","author":"Scheuer","journal-title":"Clin Chim Acta"},{"issue":"3","key":"R19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/193229681300700311","article-title":"Impact of glucose measurement processing delays on clinical accuracy and relevance","volume":"7","author":"Jangam","journal-title":"J Diabetes Sci Technol"},{"issue":"22","key":"R20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16224488","article-title":"Real-world gestational diabetes screening: problems with the oral glucose tolerance test in rural and remote Australia","volume":"16","author":"Jamieson","journal-title":"Int J Environ Res Public Health"}],"container-title":["JMIR Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetes.jmir.org\/2026\/1\/e69695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:57:44Z","timestamp":1782842264000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetes.jmir.org\/2026\/1\/e69695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2196\/69695","relation":{},"ISSN":["2371-4379"],"issn-type":[{"value":"2371-4379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"article-number":"v11i5e69695"}}